Page 323 - Read Online

Page 14 of 15 Chen et al. Hepatoma Res 2018;4:29 I http://dx.doi.org/10.20517/2394-5079.2018.18

89. Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular
signaling proteins. Science 1994;264:1415-21.
90. Wang S, Sun Y. The IL-6/JAK/STAT3 pathway: potential therapeutic strategies in treating colorectal cancer (Review). Int J Oncol
2014;44:1032-40.
91. Zheng Y, Li X, Zhao H, Zhao J. Effect of matrine and oxymatrine on proliferation and expression of Stat3 and Stat5 in SMMC-7721
cell line. Zhongguo Zhong Yao Za Zhi 2008;33:2234-7. (in Chinese)
92. Wonganan O, He Y, Shen X, Wongkrajang K, Suksamrarn A, Zhang G, Wang F. 6-Hydroxy-3-O-methyl-kaempferol 6-O-glucopyranoside
potentiates the anti-proliferative effect of interferon α/β by promoting activation of the JAK/STAT signaling by inhibiting SOCS3 in
hepatocellular carcinoma cells. Toxicol Appl Pharmacol 2017;336:31-9.
93. Ilamathi M, Prabu P, Ayyappa K, Sivaramakrishnan V. Artesunate obliterates experimental hepatocellular carcinoma in rats through
suppression of IL-6-JAK-STAT signalling. Biomed Pharmacother 2016;82:72-9.
94. Zhou G, Yi Y, Jin L, Lin W, Fang P, Lin X, Zheng Y, Pan C. The protective effect of juglanin on fructose-induced hepatitis by
inhibiting inflammation and apoptosis through TLR4 and JAK2/STAT3 signaling pathways in fructose-fed rats. Biomed Pharmacother
2016;81:318-28.
95. Wang B, Liu T, Wu J, Luo S, Chen R, Lu L, Xu M. STAT3 aggravates TGF-β1-induced hepatic epithelial-to-mesenchymal transition
and migration. Biomed Pharmacother 2017;98:214-21.
96. Sihver W, Pietzsch J, Krause M, Baumann M, Steinbach J, Pietzsch H. Radiolabeled cetuximab conjugates for EGFR targeted cancer
diagnostics and therapy. Pharmaceuticals (Basel) 2014;7:311-38.
97. Tan X, Lambert P, Rapraeger A, Anderson R. Stress-induced EGFR trafficking: mechanisms, functions, and therapeutic implications.
Trends Cell Biol 2016;26:352-66.
98. Dang Z, Shangguan J, Zhang C, Hu P, Ren Y, Lv Z, Xiang H, Wang X. Loss of protocadherin-17 (PCDH-17) promotes metastasis and
invasion through hyperactivation of EGFR/MEK/ERK signaling pathway in hepatocellular carcinoma. Tumour Biol 2016;37:2527-35.
99. Wang R, Chen L, Chen H, Hu L, Li L, Sun H, Jiang F, Zhao J, Liu G, Tang J, Chen C, Yang Y, Chang Y, Liu H, Zhang J, Yang Y, Huang
G, Shen F, Wu M, Zhou W, Wang H. MUC15 inhibits dimerization of EGFR and PI3K-AKT signaling and is associated with aggressive
hepatocellular carcinomas in patients. Gastroenterology 2013;145:1436-48.e1-12.
100. Li R, Yanjiao G, Wubin H, Yue W, Jianhua H, Huachuan Z, Rongjian S, Zhidong L. Secreted GRP78 activates EGFR-SRC-STAT3
signaling and confers the resistance to sorafeinib in HCC cells. Oncotarget 2017;8:19354-64.
101. Chen L, Fu W, Zheng L, Wang Y, Liang G. Recent progress in the discovery of myeloid differentiation 2 (MD2) modulators for
inflammatory diseases. Drug Discov Today 2018;23:1187-202.
102. Uthaya Kumar D, Chen C, Liu J, Feldman D, Sher L, French S, DiNorcia J, French S, Naini B, Junrungsee S, Agopian V, Zarrinpar A,
Machida K. TLR4 signaling via NANOG cooperates with STAT3 to activate Twist1 and promote formation of tumor-initiating stem-like
cells in livers of mice. Gastroenterology 2016;150:707-19.
103. Wen J, Zhu F, Chen W, Jiang L, Chen J, Hu Z, Huang Y, Zhou Z, Wang G, Lin H, Zhou S. Oxymatrine improves intestinal epithelial
barrier function involving NF-κB-mediated signaling pathway in CCl4-induced cirrhotic rats. PLoS One 2014;9:e106082.
104. Miyazaki M, Kanto T, Inoue M, Itose I, Miyatake H, Sakakibara M, Yakushijin T, Kakita N, Hiramatsu N, Takehara T, Kasahara
A, Hayashi N. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced
expression of Toll-like receptors and retinoic acid inducible gene-I. J Med Virol 2008;80:980-8.
105. Liu M, Xu Y, Han X, Yin L, Xu L, Qi Y, Zhao Y, Liu K, Peng J. Dioscin alleviates alcoholic liver fibrosis by attenuating hepatic stellate
cell activation via the TLR4/MyD88/NF-κB signaling pathway. Sci Rep 2015;5:18038.
106. Heger M, van Golen R, Broekgaarden M, Michel M. The molecular basis for the pharmacokinetics and pharmacodynamics of curcumin
and its metabolites in relation to cancer. Pharmacol Rev 2014;66:222-307.
107. Kadasa N, Abdallah H, Afifi M, Gowayed S. Hepatoprotective effects of curcumin against diethyl nitrosamine induced hepatotoxicity in
albino rats. Asian Pac J Cancer Prev 2015;16:103-8.
108. El-Houseini M, El-Agoza I, Sakr M, El-Malky G. Novel protective role of curcumin and taurine combination against experimental
hepatocarcinogenesis. Exp Ther Med 2017;13:29-36.
109. Halls C, Yu O. Potential for metabolic engineering of resveratrol biosynthesis. Trends Biotechnol 2008;26:77-81.
110. Yu H, Pan C, Zhao S, Wang Z, Zhang H, Wu W. Resveratrol inhibits tumor necrosis factor-alpha-mediated matrix metalloproteinase-9
expression and invasion of human hepatocellular carcinoma cells. Biomed Pharmacother 2008;62:366-72.
111. Uchida Y, Yamazaki H, Watanabe S, Hayakawa K, Meng Y, Hiramatsu N, Kasai A, Yamauchi K, Yao J, Kitamura M. Enhancement of
NF-kappaB activity by resveratrol in cytokine-exposed mesangial cells. Clin Exp Immunol 2005;142:76-83.
112. Chai R, Fu H, Zheng Z, Liu T, Ji S, Li G. Resveratrol inhibits proliferation and migration through SIRT1 mediated post-translational
modification of PI3K/AKT signaling in hepatocellular carcinoma cells. Mol Med Rep 2017;16:8037-44.
113. Piotrowska H, Kujawska M, Nowicki M, Petzke E, Ignatowicz E, Krajka-Kuźniak V, Zawierucha P, Wierzchowski M, Murias
M, Jodynis-Liebert J. Effect of resveratrol analogue, DMU-212, on antioxidant status and apoptosis-related genes in rat model of
hepatocarcinogenesis. Hum Exp Toxicol 2017;36:160-75.
114. Zhang Z, Zhao S, Yao Z, Wang L, Shao J, Chen A, Zhang F, Zheng S. Autophagy regulates turnover of lipid droplets via ROS-
dependent Rab25 activation in hepatic stellate cell. Redox Biol 2017;11:322-34.
115. Zaki S, Ahmed E, Motawie A, Abdel Fattah S. N-acetylcysteine versus progesterone on the cisplatin-induced peripheral neurotoxicity.
Folia Morphol (Warsz) 2018;77:234-45.
116. Cheng B, Anand P, Kuang A, Akhtar F, Scofield V. N-acetylcysteine in combination with IGF-1 enhances neuroprotection against
proteasome dysfunction-induced neurotoxicity in SH-SY5Y cells. Parkinsons Dis 2016;2016:6564212.